HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $58 Price Target
HC Wainwright & Co. Reiterates Buy on Mirum Pharmaceuticals, Maintains $58 Price Target
HC Wainwright & Co. 重申對 Mirum Pharmaceuticals 的買入評級,維持 58 美元的目標價格。
HC Wainwright & Co. reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy and maintains $58 price target.
HC Wainwright & Co. 重申對mirum pharmaceuticals (NASDAQ: MIRM)的買入評級,目標price target維持在58美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。